Lesaffre International
14
3
3
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
28.6%
4 terminated/withdrawn out of 14 trials
63.6%
-22.9% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
A Decentralized Clinical Study Evaluating the Effectiveness of Two Different Doses of MyCondro™ on Physical Mobility and Joint Health
Role: lead
Relationship Between Skin Microbiome, Epigenetic Age, and Facial Features in Aging
Role: lead
Vitamin K2 Supplementation in Adult Episodic Migraine
Role: collaborator
Animal and Microbial-based Dietary Protein Efficiency in Adults
Role: collaborator
BSCU1 and Immune Function
Role: lead
Bioavailability Study of Folate in Healthy Subjects
Role: lead
Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype
Role: lead
Effect of Oral Probiotic Yeast on the Composition of the Vaginal Microbiota in Healthy Women
Role: lead
Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis
Role: lead
Effect of Saccharomyces Cerevisiae in LDL Cholesterol
Role: lead
Clinical Trial to Determine the Bioavailability of Three Different Zinc Preparations
Role: lead
Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction
Role: collaborator
Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis
Role: lead
Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome
Role: lead
All 14 trials loaded